RYTM logo

RHYTHM PHARMACEUTICALS INC

RYTMNASDAQ
🏆 #921 by market capEarnings Nov 2US Equity
$115.39▲ $2.61 (+2.26%)
Live
1h▲ 0.7%
24h▲ 2.3%
7d▲ 4.4%
14d▲ 8.4%
30d▲ 7.5%
1y▲ 19.6%
🏦Market Cap
$7.91B
Small Cap
📈Revenue Growth (YoY)
+53.5%
High Growth
📊Gross Margin
70.9%
High
💵FCF Margin
—
⚖️P/S Ratio
33.0x
Expensive
Otter Score
56
Weak
📊

Analyst Ratings

Price
$115.39
Total
21
Raised
1
Lowered
0
Avg PT
$144.43
H / L
$160 / $125
InstitutionActionRatingDate
Citigroup
ReiteratedBuy2026-08-05
RBC Capital
ReiteratedOutperform2026-08-05
Citizens
ReiteratedMarket Outperform2026-08-05
Canaccord Genuity
ReiteratedBuy2026-06-16
Wells Fargo
ReiteratedOverweight2026-06-15
HC Wainwright & Co.
ReiteratedBuy2026-03-23
B of A Securities
ReiteratedBuy2026-03-20
HC Wainwright& Co.
ReiteratedBuy2026-03-18
Morgan Stanley
ReiteratedOverweight2026-03-17
Needham
ReiteratedBuy2026-03-17
Guggenheim
ReiteratedBuy2026-02-27
Goldman Sachs
ReiteratedBuy2025-12-12
JMP Securities
ReiteratedMarket Outperform2025-09-25
Leerink Partners
ReiteratedOutperform2025-07-10
Oppenheimer
ReiteratedOutperform2025-07-10
Stifel
ReiteratedBuy2025-05-29
TD Cowen
ReiteratedBuy2024-11-06
Ladenburg Thalmann
ReiteratedBuy2023-03-02
Stifel Nicolaus
UpgradedHold → Buy2019-07-12
Cowen & Co.
ReiteratedOutperform2017-10-30
Bank of America
ReiteratedBuy2017-10-30
One row per institution, most recent rating